Amyris and BASF to partner on R&D

Usually announcements like this don't move the needle much but shares of Amyris (AMRS +15.6%) are up nicely this morning in apparent response to its collaboration with BASF.

The company will use its synthetic biology and strain engineering platform to develop a microorganism capable of producing a BASF-targeted molecule.

No financial terms are disclosed.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs